Faculty Spotlight
Get to know our faculty members, and gain further information surrounding their backgrounds and expertise, through multimedia videos.
13th Annual CMHC Boston
CMHC Chair Christie M. Ballantyne, MD and faculty member Marc S. Sabatine, MD share highlights on the 13th Annual CMHC in Boston.
Jason Tregellas, MD
CMHC Faculty member, Jason Tregellas, MD shares on the impact of exercise on mental and cardiovascular health.
Robert Eckel, MD | Dan Bessesen, MD | Sangeeta Kashyap, MD | Nin T. Nguyen, MD
CMHC Chair Robert H. Eckel, M.D. leads a panel discussion on various approaches to the treatment of type 2 diabetes.
Robert Eckel, MD and Alan Chait, MD
CMHC faculty member Alan Chait, M.D. shares insight on the use of animal models in researching cardiovascular inflammation.
Ken Fujioka, MD
CMHC West Chair, Ken Fujioka, MD shares on the importance of emphasizing weight loss in the management of type 2 diabetes.
Jay Skyler, MD | Steven Kahn, MD | Leigh Perrault, MD | Sanjay Kaul, MD
CMHC Faculty members discuss the latest clinical research in cardiometabolic health.
Clyde Yancy, MD, Bykem Bozkurt, MD, Gurusher Panjrath, MD
CMHC Faculty members discuss the importance of addressing co-morbidities in heart disease.
Mini Panel Disucssion with Academic Experts in Nephrology and Endocrinology
CMHC Faculty Member discusses the newest therapeutic strategies in cardiometabolic health with nephrologist Lance Sloan, MD and endocrinologist Yehuda Handelsman, MD.
Keith Ferdinand, MD | JoAnn Lindenfeld, MD | Alanna Morris, MD
CMHC Chair, Keith C. Ferdinand, MD leads panel discussion with faculty members, JoAnn Lindenfeld, MD and Alanna A. Morris, MD on the current state of HFpEF intervention options.
Matthew Stryker, MD | Kim Cirtcher, MD
CMHC faculty members Matthew Stryker and Kim Birtcher lead a discussion on prior authorization.
Robert Eckel, MD | Keith Ferdinand, MD
CMHC Chair Robert Eckel and Senior Planning Committee member Keith Ferdinand discuss the importance of cardiometabolic health and the importance of attending the Annual Cardiometabolic Health Congress.
Kate Kirley | Janet Williams
CMHC faculty members Kate Kirley and Janet Williams lead a discussion on their AMA workshops
Irl Hirsch, MD | Anne Peters, MD
CMHC faculty members Irl Hirsch and Anne Peters talk about CGM management
Robert Eckel, MD | Robert Kushner, MD
CMHC Chair Robert Eckel and CMHC faculty member Robert Kushner lead a discussion on obesity management
Jay Skylar, MD | C. Ronald Kahn, MD
CMHC Chair Jay Skyler and CMHC Keynote presenter C. Ronald Kahn discuss Dr. Kahn's keynote presentation regarding his work with insulin receptors and insulin resistance in diabetes and obesity
Keith Ferdinand, MD | JoAnn Lindenfeld, MD | Alanna Morris, MD
CMHC Senior Planning Committee member Keith Ferdinand and CMHC faculty member Alanna Morris, and JoAnn Lindenfeld discuss the importance of HFpEF management
Ken Fujioka, MD | Spero M. Manson, PhD
CMHC West Chair Ken Fujioka, M.D. and CMHC West Keynote speaker Spero M. Manson, PhD discuss the impact of the Special Diabetes Program for Indians.
Christie M. Ballantyne, MD | Salim Virani, MD, PhD, FACC, FAHA
CMHC Chair, Christie M. Ballantyne, MD and Salim Virani, MD, PhD discuss the latest cholesterol guidelines
Ken Fujioka, MD | Alice Lichtenstein, DSc | Andrew Freeman, MD | Kim A. Williams, Sr., MD
CMHC West Chair Ken Fujioka, M.D. leads a spirited panel discussion on the current state of dietary approaches for cardiometabolic health with Alice Lichtenstein, DSc, Andrew Freeman, MD and Kim A. Williams, Sr., MD.
Christie M. Ballantyne, MD | Deepak L. Bhatt, MD, MPH
CMHC Chair, Christie M. Ballantyne, MD and Senior Planning Committee member Deepak L. Bhatt, MD, MPH discuss antithrombotics in diabetic patients.
Christie M. Ballantyne, MD | Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA
CMHC Chair, Christie M. Ballantyne, MD and Senior Planning Committee member Pamela B. Morris, MD discuss the new era of LDL-C lowering.
George L. Bakris, MD | Clyde W. Yancy, MD, MSc, MACP
CMHC Chair, George L. Bakris, MD and Senior Planning Committee member Clyde W. Yancy, MD, MSc, MACP discuss gender equality and race issues in the treatment of heart failure.
Jay S. Skyler, MD, MACP | Irl B. Hirsch, MD
CMHC Chair, Jay S. Skyler and Irl B. Hirsch, MD discuss insulin access and cost
Jay S. Skyler, MD, MACP | Lawrence Blonde, MD
CMHC Chair, Jay S. Skyler and Lawrence Blonde, MD discuss the updates on cardiovascular outcomes trials.
Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA | Ralph La Forge, MSc, FNLA, CLS
CMHC Women’s Health Summit Chair, Pamela B. Morris, MD and Ralph La Forge, MSc, FNLA, CLS discuss cardiometabolic risk management in American Indians and Alaska Native Women.
Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA | Deepak L. Bhatt, MD, MPH
CMHC Women’s Health Summit Chair, Pamela B. Morris, MD and Deepak L. Bhatt, MD, MPH discuss the role of aspirin therapy for CVD prevention in women.
Robert H. Eckel, MD | Christos S. Mantzoros, MD, DSc
CMHC Chair Robert H. Eckel, M.D., and faculty member Christos S. Mantzoros, MD, discuss how fatty liver diseases such as NASH, NAFLD, etc., are directly related to cardiometabolic diseases.
A division of Tarsus Medical owned by Tarsus PLC
Cardiometabolic Health Congress.
All Rights Reserved.
